Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Intestinal2466 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A07880 | 32325178 | J Ethnopharmacol | Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice. | 2020 | Details |
| A07882 | 32324317 | J Cell Mol Med | GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway. | 2020 | Details |
| A07885 | 32323179 | Adv Exp Med Biol | Gut Microbiota and Liver Injury (II): Chronic Liver Injury. | 2020 | Details |
| A07907 | 32315005 | Food Funct | Alleviating effects of noni fruit polysaccharide on hepatic oxidative stress and inflammation in rats under a high-fat diet and its possible mechanisms. | 2020 | Details |
| A07908 | 32314869 | J Cell Mol Med | Pro-inflammatory signalling and gut-liver axis in non-alcoholic and alcoholic steatohepatitis: Differences and similarities along the path. | 2020 | Details |
| A07925 | 32306666 | Zhonghua Gan Zang Bing Za Zhi | [Circadian clock and non-alcoholic fatty liver disease]. | 2020 | Details |
| A07932 | 32306650 | Zhonghua Gan Zang Bing Za Zhi | [Emphasis on clinical study of heterogeneity of non-alcoholic fatty liver disease]. | 2020 | Details |
| A07966 | 32296880 | J Mol Med (Berl) | HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLD. | 2020 | Details |
| A07968 | 32295122 | Nutrients | Extra-Virgin Olive Oil from Apulian Cultivars and Intestinal Inflammation. | 2020 | Details |
| A07969 | 32294235 | Eur J Clin Invest | Macrophages in the pathophysiology of NAFLD: The role of sex differences. | 2020 | Details |
| A07978 | 32291578 | Indian J Gastroenterol | Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. | 2020 | Details |
| A07979 | 32291277 | Diabetes Care | Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes. | 2020 | Details |
| A08004 | 32282030 | Br Med Bull | Obeticholic acid-a new therapy in PBC and NASH. | 2020 | Details |
| A08032 | 32275114 | FASEB J | Western diet-induced increase in colonic bile acids compromises epithelial barrier in nonalcoholic steatohepatitis. | 2020 | Details |
| A08054 | 32267559 | J Gastroenterol Hepatol | Phenotyping non-alcoholic fatty liver disease by the gut microbiota: Ready for prime time? | 2020 | Details |
| A08087 | 32252638 | BMC Gastroenterol | Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study. | 2020 | Details |
| A08103 | 32245414 | BMC Gastroenterol | Incidence, aetiology and related comorbidities of cirrhosis: a Swedish population-based cohort study. | 2020 | Details |
| A08105 | 32245128 | Nutrients | Increase of Akkermansia muciniphila by a Diet Containing Japanese Traditional Medicine Bofutsushosan in a Mouse Model of Non-Alcoholic Fatty Liver Disease. | 2020 | Details |
| A08109 | 32244182 | Mol Metab | Impact of global PTP1B deficiency on the gut barrier permeability during NASH in mice. | 2020 | Details |
| A08111 | 32243703 | Liver Int | Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease. | 2020 | Details |
| A08113 | 32243137 | Bioconjug Chem | New Generation Oxyntomodulin Peptides with Improved Pharmacokinetic Profiles Exhibit Weight Reducing and Anti-Steatotic Properties in Mice. | 2020 | Details |
| A08115 | 32241197 | Expert Rev Gastroenterol Hepatol | Obeticholic acid for the treatment of nonalcoholic steatohepatitis. | 2020 | Details |
| A08128 | 32237916 | Expert Opin Pharmacother | Current and new pharmacotherapy options for non-alcoholic steatohepatitis. | 2020 | Details |
| A08133 | 32235497 | Nutrients | Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. | 2020 | Details |
| A08143 | 32230987 | Nutrients | Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08144 | 32230953 | Nutrients | Inflammation in Primary and Metastatic Liver Tumorigenesis-Under the Influence of Alcohol and High-Fat Diets. | 2020 | Details |
| A08150 | 32228300 | Gut Microbes | Maternal sucralose intake alters gut microbiota of offspring and exacerbates hepatic steatosis in adulthood. | 2020 | Details |
| A08151 | 32226996 | Food Funct | The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet. | 2020 | Details |
| A08171 | 32219261 | Food Funct | The protective mechanisms of macroalgae Laminaria japonica consumption against lipid metabolism disorders in high-fat diet-induced hyperlipidemic rats. | 2020 | Details |
| A08174 | 32218179 | Biomolecules | A Sweet Connection? Fructose's Role in Hepatocellular Carcinoma. | 2020 | Details |
| A08178 | 32217466 | J Nutr Biochem | The modulation of Luffa cylindrica (L.) Roem supplementation on gene expression and amino acid profiles in liver for alleviating hepatic steatosis via gut microbiota in high-fat diet-fed mice: insight from hepatic transcriptome analysis. | 2020 | Details |
| A08186 | 32214246 | Nature | Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. | 2020 | Details |
| A08206 | 32205419 | Gut | Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. | 2020 | Details |
| A08209 | 32204538 | Nutrients | Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan. | 2020 | Details |
| A08288 | 32168769 | Int J Mol Sci | Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. | 2020 | Details |
| A08298 | 32163832 | J Nutr Biochem | Housing condition-associated changes in gut microbiota further affect the host response to diet-induced nonalcoholic fatty liver. | 2020 | Details |
| A08305 | 32158763 | Front Med (Lausanne) | Attenuation of the Hepatoprotective Effects of Ileal Apical Sodium Dependent Bile Acid Transporter (ASBT) Inhibition in Choline-Deficient L-Amino Acid-Defined (CDAA) Diet-Fed Mice. | 2020 | Details |
| A08313 | 32156377 | Food Res Int | Effect of okra fruit powder supplementation on metabolic syndrome and gut microbiota diversity in high fat diet-induced obese mice. | 2019 | Details |
| A08319 | 32153044 | J Gastroenterol Hepatol | Effect of weight loss induced by laparoscopic sleeve gastrectomy on liver histology and serum adipokine levels. | 2020 | Details |
| A08325 | 32152478 | Nat Rev Gastroenterol Hepatol | Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. | 2020 | Details |
| A08329 | 32151020 | Nutrients | Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD). | 2020 | Details |
| A08331 | 32150306 | J Gastroenterol Hepatol | Endogenous ethanol produced by intestinal bacteria induces mitochondrial dysfunction in non-alcoholic fatty liver disease. | 2020 | Details |
| A08336 | 32149275 | JHEP Rep | Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism. | 2019 | Details |
| A08337 | 32149099 | Biomed Res Int | Liraglutide Attenuates Nonalcoholic Fatty Liver Disease by Modulating Gut Microbiota in Rats Administered a High-Fat Diet. | 2020 | Details |
| A08341 | 32147363 | J Hepatol | Newly identified peptide hormone inhibits intestinal fat absorption and improves NAFLD through its receptor GPRC6A. | 2020 | Details |
| A08346 | 32147075 | Complement Ther Med | Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2020 | Details |
| A08451 | 32105727 | Gastroenterology | TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice. | 2020 | Details |
| A08462 | 32102237 | Int J Mol Sci | Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma. | 2020 | Details |
| A08509 | 32081971 | Sci Rep | CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis. | 2020 | Details |
| A08522 | 32075905 | J Biol Chem | Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice. | 2020 | Details |
| A08544 | 32066758 | Sci Rep | A Microbial Signature Identifies Advanced Fibrosis in Patients with Chronic Liver Disease Mainly Due to NAFLD. | 2020 | Details |
| A08599 | 32044821 | Eur J Gastroenterol Hepatol | Non-alcoholic fatty liver disease in inflammatory bowel disease patients. | 2020 | Details |
| A08601 | 32044317 | Gastroenterology | Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity? | 2020 | Details |
| A08617 | 32040876 | Lipids | Gut microbial fatty acid metabolites (KetoA and KetoC) affect the progression of nonalcoholic steatohepatitis and reverse cholesterol transport metabolism in mouse model. | 2020 | Details |
| A08635 | 32037512 | Br J Pharmacol | P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway. | 2020 | Details |
| A08636 | 32037278 | Hepatobiliary Pancreat Dis Int | Human microbiome is a diagnostic biomarker in hepatocellular carcinoma. | 2020 | Details |
| A08638 | 32036510 | Dig Dis Sci | Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08655 | 32031871 | Am J Physiol Heart Circ Physiol | Gut microbiome of a porcine model of metabolic syndrome and HF-pEF. | 2020 | Details |
| A08681 | 32024509 | BMC Complement Med Ther | Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats. | 2020 | Details |
| A08694 | 32020359 | Dig Dis Sci | Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction. | 2020 | Details |
| A08696 | 32019793 | mBio | Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08700 | 32018285 | Dtsch Med Wochenschr | [Secondary causes of fatty liver disease - an update on pathogenesis, diagnosis and treatment strategies]. | 2020 | Details |
| A08719 | 32012315 | Biomed Chromatogr | Systematic investigation on the chemical basis of anti-NAFLD Qushi Huayu Fang. Part 1: A study of metabolic profiles in vivo and in vitro by high-performance liquid chromatography-quadrupole time-of-flight mass spectrometry. | 2020 | Details |
| A08740 | 32005283 | Trials | Effect of Daesiho-tang on obesity with non-alcoholic fatty liver disease: a study protocol for a randomised, double-blind, placebo-controlled pilot trial. | 2020 | Details |
| A08741 | 32004929 | J Nutr Biochem | Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet. | 2020 | Details |
| A08745 | 32003601 | Am J Physiol Gastrointest Liver Physiol | Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH. | 2020 | Details |
| A08760 | 31998283 | Front Immunol | Absence of the Caspases 1/11 Modulates Liver Global Lipid Profile and Gut Microbiota in High-Fat-Diet-Induced Obese Mice. | 2020 | Details |
| A08776 | 31987796 | Gastroenterology | Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease. | 2020 | Details |
| A08782 | 31986416 | Biomed Pharmacother | Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis. | 2020 | Details |
| A08788 | 31984787 | Am J Physiol Gastrointest Liver Physiol | Vitamin D signaling maintains intestinal innate immunity and gut microbiota: potential intervention for metabolic syndrome and NAFLD. | 2020 | Details |
| A08818 | 31979147 | Nutrients | The Effects of Gelatinized Wheat Starch and High Salt Diet on Gut Microbiota and Metabolic Disorder. | 2020 | Details |
| A08823 | 31978054 | PLoS One | The association between nonalcoholic fatty liver disease and esophageal, stomach, or colorectal cancer: National population-based cohort study. | 2020 | Details |
| A08824 | 31976003 | Evid Based Complement Alternat Med | Sesamin, a Naturally Occurring Lignan, Inhibits Ligand-Induced Lipogenesis through Interaction with Liver X Receptor Alpha (LXRα) and Pregnane X Receptor (PXR). | 2019 | Details |
| A08832 | 31973214 | Nutrients | Murine Genetic Background Overcomes Gut Microbiota Changes to Explain Metabolic Response to High-Fat Diet. | 2020 | Details |
| A08841 | 31969314 | Pak J Pharm Sci | REVIEW- Contemporary evidence on the dynamic role of probiotics in liver diseases. | 2019 | Details |
| A08842 | 31969089 | Curr Pharm Des | NAFLD at the Interface of the Mother-Infant Dyad. | 2020 | Details |
| A08852 | 31965894 | Gut Microbes | Lactobacillus and Pediococcus ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiome. | 2020 | Details |
| A08877 | 31954488 | J Hepatol | Gut microbiome in HCC - Mechanisms, diagnosis and therapy. | 2020 | Details |
| A08882 | 31953338 | Appl Environ Microbiol | Akkermansia muciniphila Prevents Fatty Liver Disease, Decreases Serum Triglycerides, and Maintains Gut Homeostasis. | 2020 | Details |
| A08883 | 31953228 | Biochim Biophys Acta Mol Cell Biol Lipids | Effects of peptidoglycan on the development of steatohepatitis. | 2020 | Details |
| A08891 | 31950772 | Diabetes Metab J | Combination of Probiotics and Salvia miltiorrhiza Polysaccharide Alleviates Hepatic Steatosis via Gut Microbiota Modulation and Insulin Resistance Improvement in High Fat-Induced NAFLD Mice. | 2019 | Details |
| A08919 | 31937803 | Sci Rep | Integrative analysis of blood and gut microbiota data suggests a non-alcoholic fatty liver disease (NAFLD)-related disorder in French SLAdd minipigs. | 2020 | Details |
| A08923 | 31936799 | Cells | Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis. | 2020 | Details |
| A08930 | 31933238 | Pharmaceut Med | Applying Non-Invasive Fibrosis Measurements in NAFLD/NASH: Progress to Date. | 2019 | Details |
| A08969 | 31921729 | Front Pediatr | Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A08981 | 31916360 | Liver Int | Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high-risk gastro-oesophageal varices in a Chilean cohort. | 2020 | Details |
| A08996 | 31910634 | Arch Iran Med | Fecal Microbiota in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: A Systematic Review. | 2020 | Details |
| A09009 | 31905727 | Nutrients | Intestinal Fructose and Glucose Metabolism in Health and Disease. | 2019 | Details |
| A09025 | 31900291 | Gut | Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease. | 2020 | Details |
| A09073 | 31883528 | Lipids Health Dis | Pathophysiological importance of bile cholesterol reabsorption: hepatic NPC1L1-exacerbated steatosis and decreasing VLDL-TG secretion in mice fed a high-fat diet. | 2019 | Details |
| A09086 | 31881272 | Pharmacol Res | The gut-liver-kidney axis: Novel regulator of fatty liver associated chronic kidney disease. | 2019 | Details |
| A09091 | 31880257 | Curr Protein Pept Sci | Role of BCL-2 Family Proteins in Apoptosis and its Regulation by Nutrients. | 2020 | Details |
| A09095 | 31877961 | Nutrients | Switching to a Healthy Diet Prevents the Detrimental Effects of Western Diet in a Colitis-Associated Colorectal Cancer Model. | 2019 | Details |
| A09179 | 31846961 | Lifestyle Genom | One-Carbon Metabolism and Nonalcoholic Fatty Liver Disease: The Crosstalk between Nutrients, Microbiota, and Genetics. | 2019 | Details |
| A09184 | 31845054 | J Gastroenterol | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives. | 2019 | Details |
| A09195 | 31840358 | Hepatol Res | Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. | 2020 | Details |
| A09201 | 31838076 | Gastroenterology | Lactotrehalose, an Analog of Trehalose, Increases Energy Metabolism Without Promoting Clostridioides difficile Infection in Mice. | 2019 | Details |
| A09227 | 31828683 | Eur J Clin Microbiol Infect Dis | Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies. | 2019 | Details |
| A09257 | 31815784 | Curr Opin Endocrinol Diabetes Obes | Gastrointestinal peptides and nonalcoholic fatty liver disease. | 2020 | Details |
| A09291 | 31803887 | Food Funct | The regulatory effects of phytosterol esters (PSEs) on gut flora and faecal metabolites in rats with NAFLD. | 2020 | Details |